Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival-Reference-Cited by-同舟云学术

Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival

Published:2018-01 Issue: Volume:98 Page:41-49
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Nakamura Yuko,Kawaoka Tomokazu,Higaki Toru,Fukumoto Wataru,Honda Yukiko,Iida Makoto,Fujioka Chikako,Kiguchi Masao,Aikata Hiroshi,Chayama Kazuaki,Awai Kazuo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference36 articles.

1. Hepatocellular carcinoma;El-Serag;N. Engl. J. Med.,2011

2. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5;Liu;Cancer Res.,2006

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

4. Treatment of hepatocellular carcinoma with sorafenib − focus on special populations and adverse event management;Schott;Z. Gastroenterol.,2012

5. Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study;Llovet;J. Clin. Oncol.,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy;World Journal of Gastroenterology;2023-03-21

2. Applications of quantitative perfusion MRI in the liver;Advances in Magnetic Resonance Technology and Applications;2023

3. Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies;Journal of Vascular and Interventional Radiology;2022-09

4. A Systematic Review on the Role of the Perfusion Computed Tomography in Abdominal Cancer;Dose-Response;2021-10

5. Progress of MRI Radiomics in Hepatocellular Carcinoma;Frontiers in Oncology;2021-09-20